AHA - American Hospital Association
06/27/2022 | News release | Distributed by Public on 06/27/2022 14:44
FDA revokes EUAs for two SARS-CoV-2 tests
The Food and Drug Administration today announced it has revoked the emergency use authorizations for the Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test and Simoa SARS-CoV-2 N Protein Antigen Test because no viable (non-expired) tests remain.